居裡 CRIS 深 滬
等待開盤 08-07 09:30:00 美东时间
1.67
0.000
0.00%
華盛通- 最 高1.82
- 今 開1.68
- 成交量 5.15万股
- 最 低 1.65
- 昨 收 1.67
- 總市值 1747.20万
- 52周最高 8.29
- 市盈率 靜 --
- 換手率 0.49%
- 52周最低 1.02
- 委 比 21.26%
- 總股本 1046.23万
- 歷史最高 565.00
- 量 比 0.77
- 振 幅 10.18%
- 歷史最低 1.02
- 每 手 1
- 風險率 1.34%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Curis Q2 EPS $(0.68) Beats $(1.36) Estimate, Sales $2.75M Beat $2.64M Estimate
Curis (NASDAQ:CRIS) reported quarterly losses of $(0.68) per share which beat the analyst consensus estimate of $(1.36) by 50 percent. This is a 66.5 percent increase over losses of $(2.03) per share from the same period
08-05 20:02
Curis Provides Second Quarter 2025 Business Update
Management to host conference call and webcast today at 8:30 a.m. ET LEXINGTON, Mass., Aug. 5, 2025 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the develop...
08-05 20:00
Earnings Scheduled For August 5, 2025
Companies Reporting Before The Bell • Silicon Laboratories (NASDAQ:SLAB) is exp...
08-05 16:32
A Peek at Curis's Future Earnings
Curis (NASDAQ:CRIS) is gearing up to announce its quarterly earnings on Tuesday...
08-05 05:04
Curis Announces $7M Securities Purchase Agreement
Curis ( ($CRIS) ) just unveiled an announcement. On July 2, 2025, Curis, Inc. a...
07-02 20:57
Curis Announces $7M Registered Direct Offering And Private Placement, Selling 1.54M Shares At $2.275 Each; The Combined Purchase Price For 1 Share And The Associated Common Warrant Is $2.275; Combined Purchase Price For 1 Pre-Funded Warrant And The Associated Common Warrant Is $2.265
Curis, Inc. ("Curis") (NASDAQ:CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today announced that it has entered into a definitive
07-02 20:36
2024 年全球大型药企薪酬最高十位 CEO
（转自：抗体圈） 尽管在 Fierce 的 2024 年制药公司首席执行官薪酬排行榜上出现了许多熟悉的名字，但多位高管的排名发生了巨大变化，而第一名被一位黑马候...
06-18 11:23
江苏省市场监督管理局关于23批次食品抽检不合格情况的通告（2025年第7期）
省市场监督管理局关于23批次食品抽检不合格情况的通告（2025年第7期） 近期，江苏省市场监督管理局组织食品安全抽检，抽取食用农产品、粮食加工品、糕点、炒货食...
05-26 14:44
东吴证券-医药生物行业跟踪周报：国产创新药闪耀ASCO国际舞台-250525
（转自：研报虎） 本周、年初至今A股医药指数涨幅分别为1.8%、4.3%，相对沪深300的超额收益分别为1.9%、5.6%；本周、年初至今H股生物科技指数...
05-25 22:36
